1. Home
  2. AYTU vs SOWG Comparison

AYTU vs SOWG Comparison

Compare AYTU & SOWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • SOWG
  • Stock Information
  • Founded
  • AYTU N/A
  • SOWG 2010
  • Country
  • AYTU United States
  • SOWG United States
  • Employees
  • AYTU N/A
  • SOWG N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • SOWG Packaged Foods
  • Sector
  • AYTU Health Care
  • SOWG Consumer Staples
  • Exchange
  • AYTU Nasdaq
  • SOWG Nasdaq
  • Market Cap
  • AYTU 9.6M
  • SOWG 9.3M
  • IPO Year
  • AYTU N/A
  • SOWG N/A
  • Fundamental
  • Price
  • AYTU $2.40
  • SOWG $0.87
  • Analyst Decision
  • AYTU Strong Buy
  • SOWG
  • Analyst Count
  • AYTU 2
  • SOWG 0
  • Target Price
  • AYTU $10.00
  • SOWG N/A
  • AVG Volume (30 Days)
  • AYTU 151.8K
  • SOWG 4.4M
  • Earning Date
  • AYTU 09-25-2025
  • SOWG 08-13-2025
  • Dividend Yield
  • AYTU N/A
  • SOWG N/A
  • EPS Growth
  • AYTU N/A
  • SOWG N/A
  • EPS
  • AYTU N/A
  • SOWG N/A
  • Revenue
  • AYTU $81,659,000.00
  • SOWG $23,063,113.00
  • Revenue This Year
  • AYTU N/A
  • SOWG $6.81
  • Revenue Next Year
  • AYTU $1.05
  • SOWG N/A
  • P/E Ratio
  • AYTU $13.14
  • SOWG N/A
  • Revenue Growth
  • AYTU 0.41
  • SOWG N/A
  • 52 Week Low
  • AYTU $0.95
  • SOWG $0.52
  • 52 Week High
  • AYTU $2.85
  • SOWG $20.69
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 53.72
  • SOWG 47.63
  • Support Level
  • AYTU $2.55
  • SOWG $0.77
  • Resistance Level
  • AYTU $2.72
  • SOWG $2.12
  • Average True Range (ATR)
  • AYTU 0.14
  • SOWG 0.20
  • MACD
  • AYTU -0.02
  • SOWG -0.01
  • Stochastic Oscillator
  • AYTU 46.67
  • SOWG 7.66

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About SOWG Sow Good Inc. Common Stock

Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats.

Share on Social Networks: